This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of biologically active molecules. It serves as a key intermediate in the preparation of compounds targeting central nervous system disorders, such as anxiety, depression, and neurodegenerative diseases. Its structure, featuring both piperazine and benzylamine moieties, allows for versatile modifications, making it valuable in designing drugs with specific receptor-binding properties. Additionally, it is employed in the development of potential therapeutic agents for pain management and inflammation. Its role in medicinal chemistry highlights its importance in creating novel treatments for complex health conditions.